Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC Looking At Alternate Payment Mechanisms For New Technology

This article was originally published in The Gray Sheet

Executive Summary

The Medicare Payment Advisory Commission is finding that coverage and cost components in paying for new medical technologies cannot be easily separated

You may also be interested in...



CMS’ Limited Resources Hinder Ability To Implement Value-Based Purchasing

The Centers for Medicare & Medicaid Services' inability to fairly and accurately determine the "value" of a new device could deter the agency from utilizing value-based purchasing to pay for new technologies, according to MedPAC staff member Chantal Worzala, PhD

CMS’ Limited Resources Hinder Ability To Implement Value-Based Purchasing

The Centers for Medicare & Medicaid Services' inability to fairly and accurately determine the "value" of a new device could deter the agency from utilizing value-based purchasing to pay for new technologies, according to MedPAC staff member Chantal Worzala, PhD

Local Coverage Threshold Should Trigger National Coverage – Policy Makers

National Medicare coverage should automatically be triggered once 30-40% of local contractors or beneficiaries have established coverage, according to Charlotte Yeh, MD, medical director, Medicare policy at National Heritage Insurance Company for Northern New England

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017192

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel